News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,634 Results
Type
Article (48979)
Company Profile (351)
Press Release (672304)
Section
Business (211631)
Career Advice (2092)
Deals (36436)
Drug Delivery (97)
Drug Development (82840)
Employer Resources (171)
FDA (16741)
Job Trends (15633)
News (357518)
Policy (34860)
Tag
Academia (2829)
Alliances (51475)
Alzheimer's disease (1220)
Approvals (16653)
Artificial intelligence (111)
Bankruptcy (362)
Best Places to Work (12029)
Biotechnology (237)
Breast cancer (88)
Cancer (749)
Career advice (1753)
Cell therapy (180)
Clinical research (65105)
Collaboration (267)
Compensation (149)
COVID-19 (2701)
Cystic fibrosis (81)
Data (617)
Diabetes (114)
Diagnostics (6408)
Drug pricing (89)
Earnings (85463)
Employer resources (148)
Events (116794)
Executive appointments (229)
FDA (17106)
Funding (249)
Gene therapy (132)
GLP-1 (576)
Government (4842)
Healthcare (20113)
Infectious disease (2761)
Inflammatory bowel disease (101)
Interviews (326)
IPO (16594)
Job creations (3854)
Job search strategy (1502)
Layoffs (424)
Legal (8401)
Lung cancer (140)
Manufacturing (133)
Medical device (13745)
Medtech (13750)
Mergers & acquisitions (19799)
Metabolic disorders (336)
Neuroscience (1444)
NextGen Class of 2024 (7107)
Non-profit (4901)
Northern California (1051)
Obesity (205)
Opinion (201)
Patents (87)
People (58690)
Pharmaceutical (77)
Phase I (20260)
Phase II (28527)
Phase III (21342)
Pipeline (170)
Postmarket research (2749)
Preclinical (8615)
Radiopharmaceuticals (244)
Rare diseases (169)
Real estate (6191)
Regulatory (22753)
Research institute (2524)
Resumes & cover letters (360)
Southern California (982)
Startups (3802)
United States (10780)
Vaccines (571)
Weight loss (163)
Date
Today (134)
Last 7 days (605)
Last 30 days (2733)
Last 365 days (37699)
2024 (29687)
2023 (41416)
2022 (52681)
2021 (57395)
2020 (56371)
2019 (49507)
2018 (37493)
2017 (33684)
2016 (33774)
2015 (39838)
2014 (33490)
2013 (28531)
2012 (30715)
2011 (31329)
2010 (29613)
Location
Africa (840)
Arizona (198)
Asia (39888)
Australia (6605)
California (2449)
Canada (1093)
China (187)
Colorado (102)
Connecticut (109)
Europe (86540)
Florida (344)
Georgia (92)
Illinois (312)
Indiana (173)
Kansas (99)
Maryland (492)
Massachusetts (2002)
Michigan (150)
Minnesota (253)
New Jersey (739)
New York (747)
North Carolina (689)
Northern California (1051)
Ohio (121)
Pennsylvania (690)
South America (1213)
Southern California (982)
Texas (335)
Washington State (298)
721,634 Results for "genomic health inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program
HUNTSVILLE, Ala., March 20, 2024 – healthŌme®, Inc., a leading genomics-based, precision health management company serving the life and critical illness industries, and GalenusRx, Inc.,
March 20, 2024
·
5 min read
Business
Children’s Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis
Children’s Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis.
March 13, 2024
·
4 min read
Business
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.
June 28, 2024
·
4 min read
Business
Fabric Genomics Partners with Intermountain Children’s Health to Enhance Precision Diagnosis of Infants and Children Using Whole Genome Sequencing from Broad Clinical Labs
Fabric Genomics is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.
March 13, 2024
·
5 min read
Biotech Bay
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference on Tuesday, March 5, at 2:50 p.m. Eastern Time.
February 20, 2024
·
1 min read
Press Releases
Revival Health Inc. Partners With BSS Health to Bring Affordable GLP-1 Obesity Medication to Mississippians Following Policy Change at Mississippi Board of Medical Licensure
October 16, 2024
·
5 min read
Bio NC
SNP Therapeutics Inc and Fullscript announce Genate test integration to support health professional precision nutrition recommendations in reproductive health
SNP Therapeutics Inc announced today that its Genate Prenatal Nutrition Test can now support healthcare professionals utilizing the Fullscript platform.
June 26, 2024
·
3 min read
Biotech Bay
Jaguar Health, Inc. Announces Reverse Stock Split - May 17, 2024
Jaguar Health, Inc. announced that the Company will effect a reverse stock split of its issued and outstanding voting common stock, at an exchange ratio of 1-for-60, on Thursday, May 23, 2024 in order to support the Company’s compliance with Nasdaq’s listing standards.
May 17, 2024
·
5 min read
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time.
May 9, 2024
·
1 min read
Business
Inherent Biosciences and Genomic Prediction Announce Commercial Partnership to Advance Male Reproductive Health
Inherent Biosciences, Inc. and Genomic Prediction, Inc. (North Brunswick, NJ) are thrilled to announce a comprehensive commercial partnership agreement.
January 31, 2024
·
3 min read
1 of 72,164
Next
